Sign in →

Epic Code LAB263 Discontinued HPV High Risk Screen

Important Note

This test will be discontinued on 8/26/2024. Please order new HPV test: LAB1231770

Interface Order Alias

10719

Clinical Information

Testing is performed using the APTIMA HPV nucleic acid amplification test for the qualitative detection of E6/E7 viral messenger RNA (mRNA) from 14 high-risk human papillomavirus (HPV) types (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66 and 68) in cervical specimens collected in ThinPrep PreservCyt Solution.

 

Results are reported as positive or negative as the test does not determine the specific HPV type present or provide a quantitative viral load.

 

The use of this test is indicated:

  1. In women 30 years and older, with the results used in combination with cervical cytology to assess the presence or absence of high-risk HPV types, to guide patient management.
  2. In women 21 years or older with atypical squamous cells of undetermined significance (ASC-US) cervical cytology results to determine the need for referral to colposcopy.

 

The results of this test are not intended to prevent women from proceeding to colposcopy.

Reference Range

Negative for the 14 High Risk (HR) HPV types listed below.

Performing Department

Formerly Cytology

Performing Department Laboratory Location

Corewell Health Reference Laboratory, Grand Rapids, MI

Methodology

Aptima HPV

 

The APTIMA HPV HR Assay is an in vitro nucleic acid amplification test for the qualitative detection of

E6/E7 viral messenger RNA (mRNA) from 14 high-risk types of human papillomavirus (HPV) in

cervical specimens.

CPT

87624

CDM Code

3068762402

Epic Test ID

1230100811

LOINC

HUMAN PAPILLOMA VIRUS HIGH RISK PROBE: 59420-0

Mayo Access Code

SHO241

Reviewed Date

4/7/2023

Updated Date

8/27/24 - Discontinued